Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells

British Journal of Pharmacology

Volumn 138, Issue 1, 2003, Pages 193-201

  Yang, Shu Er ^a   Hsieh, Ming Tsuen ^a   Tsai, Tung Hu ^b   Hsu, Shih Lan ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Bad; Bcl X L; Bcl X S; Caspase; Cytochrome c; ERK; JNK; Magnolol

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 6; CASPASE 9; CYTOCHROME C; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BCL XS; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARK; CELL LINE; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN CH27; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG ISOLATION; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG SQUAMOUS CELL CARCINOMA; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; BIPHENYL COMPOUNDS; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; LIGNANS; LUNG NEOPLASMS; MAGNOLIA; MAP KINASE SIGNALING SYSTEM; PLANT BARK; PLANT EXTRACTS; TUMOR CELLS, CULTURED;

EID: 0037275601     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705024     Document Type: Article

References (52)

1. ADAMS, J.M. & CORY, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326.
2. BANG, K.H., KIM, Y.K., MIN, B.S., NA, M.K., RHEE, Y.H., LEE, J.P. & BAE, K.H. (2000). Antifungal activity of magnolol and honokiol. Arch. Pharm. Res., 23, 46-49.
3. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
4. CHANG, W.S., CHANG, Y.H., LU, F.J. & CHIANG, H.C. (1994). Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res., 14, 501-506.
5. CHEN, C.J., YOU, S.L., LIN, L.H., HSU, W.L. & YANG, Y.W. (2002). Cancer epidemiology and control in Taiwan: a brief review. Jpn J. Clin. Oncol., 32, S66-S81.
6. CHEN, Y.R., MEYER, C.F. & TAN, T.H. (1996). Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem., 271, 631-634.
7. DAVIS, R.J. (2000). Signal transduction by the JNK group of MAP kinases. Cell, 103, 239-252.
8. FRIDMAN, J.S., PARSELS, J., REHEMTULLA, A. & MAYBAUM, J. (2001). Cytochrome c depletion upon expression of Bcl-XS. J. Biol. Chem., 276, 4205-4210.
9. FRIESEN, C., HERR, I., KRAMMER, P.H. & DEBATIN, K.M. (1996). Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2, 574-577.
10. FUJITA, S. & TAIRA, J. (1994). Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic. Biol. Med., 17, 273-277.
11. FULDA, S., SIEVERTS, H., FRIESEN, C., HERR, I. & DEBATIN, K.M. (1997). The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res., 57, 3823-3829.
12. GONZALEZ-GARCIA, M., PEREZ-BALLESTERO, R., DING, L., DUAN, L., BOISE, L.H., THOMPSON, C.B. & NUNEZ, G. (1994). Bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development, 120, 3033-3042.
13. HAMASAKI, Y., KOBAYASHI, I., ZAITU, M., TSUJI, K., KITA, M., HAYASAKI, R., MURO, E., YAMAMOTO, S., MATSUO, M., ICHIMARU, T. & MIYAZAKI, S. (1999). Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells. Planta Med., 65, 222-226.
14. HIRANO, T., GOTOH, M. & OKA, K. (1994). Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci., 55, 1061-1069.
15. HO, K.Y., TSAI, C.C., CHEN, C.P., HUANG, J.S. & LIN, C.C. (2001). Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother. Res., 15, 139-141.
16. IP, Y.T. & DAVIS, R.J. (1998). Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell. Biol., 10, 205-219.
17. IWAMA, K., NAKAJO, S., AIUCHI, T. & NAKAYA, K. (2001). Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int. J. Cancer, 92, 518-526.
18. KELEKAR, A., CHANG, B.S., HARLAN, J.E., FESIK, S.W. & THOMPSON, C.B. (1997). Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol., 17, 7040-7046.
19. KHARBANDA, S., PANDEY, P., SCHOFIELD, L., ISRAELS, S., RONCINSKE, R., YOSHIDA, K., BHARTI, A., YUAN, Z.M., SAXENA, S., WEICHSELBAUM, R., NALIN, C. & KUFE, D. (1997). Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A., 94, 6939-6942.
20. KIM, C.N., WANG, X., HUANG, Y., IBRADO, A.M., LIU, L., FANG, G. & BHALLA, K. (1997). Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res., 57, 3115-3120.
21. KLEKOTKA, P.A., SANTORO, S.A., WANG, H. & ZUTTER, M.M. (2001). Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. J. Biol. Chem., 276, 32353-32361.
22. KONG, C.W., TSAI, K., CHIN, J.H., CHAN, W.L. & HONG, C.Y. (2000). Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock, 13, 24-28.
23. KONOSHIMA, T., KOZUKA, M., TOKUDA, H., NISHINO, H., IWASHIMA, A., HARUNA, M., ITO, K. & TANABE, M. (1991). Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod., 54, 816-822.
24. LEE, Y.M., HSIAO, G., CHEN, H.R., CHEN, Y.C., SHEU, J.R. & YEN, M.H. (2001). Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. Eur. J. Pharmacol., 422, 159-167.
25. LI, P., NIJHAWAN, D., BUDIHARDJO, I., SRINIVASULA, S.M., AHMAD, M., ALNEMRI, E.S. & WANG, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489.
26. LIN, S.Y., CHANG, Y.T., LIU, J.D., YU, C.H., HO, Y.S., LEE, Y.H. & LEE, W.S. (2001). Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol. Carcinog., 32, 73-83.
27. LIN, S.Y., LIU, J.D., CHANG, H.C., YEH, S.D., LIN, C.H. & LEE, W.S. (2002). Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis, J. Cell. Biochem., 84, 532-544.
28. MARUYAMA, Y., KURIBARA, H., MORITA, M., YUZURIHARA, M. & WEINTRAUB, S.T. (1998). Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. J. Nat. Prod., 61, 135-138.
29. MCDAID, H.M. & HORWITZ, S.B. (2001). Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol. Pharmacol., 60, 290-301.
30. MINDEN, A. & KARIN, M. (1997). Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta., 1333, F85-F104.
31. MINN, A.J., BOISE, L.H. & THOMPSON, C.B. (1996). Bcl-x(S) anatagonizes the protective effects of Bcl-x(L). J. Biol. Chem., 271, 6306-6312.
32. MIYAKE, H., HARA, S., ARAKAWA, S., KAMIDONO, S. & HARA, I. (2001). Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo. Int. J. Cancer, 93, 26-32.
33. NAGASE, H., IKEDA, K. & SAKAI, Y. (2001). Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med., 67, 705-708.
34. PORTER, A.G. & JANICKE, R.U. (1999). Emerging roles of caspase-3 in apoptosis. Cell Death Differ., 6, 99-104.
35. RICE, P.L., GOLDBERG, R.J., RAY, E.C., DRIGGERS, L.J. & AHNEN, D.J. (2001). Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res., 61, 1541-1547.
36. SANDSTROM, P.A. & BUTTKE, T.M. (1993). Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. U.S.A., 90, 4708-4712.
37. SCARPATI, M.D., VICIDOMINI, G. & SANTINI, M. (2001). Gemcitabine and small cell lung cancer. Lung Cancer, 34, 313-314.
38. SCHAEFFER, H.J. & WEBER, M.J. (1999). Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol., 19, 2435-2444.
39. SHINOURA, N., YOSHIDA, Y., NISHIMURA, M., MURAMATSU, Y., ASAI, A., KIRINO, T. & HAMADA, H. (1999). Expression level of Bcl-2 determines anti- or proapoptotic function. Cancer Res., 59, 4119-4128.
40. TENG, C.M., KO, F.N., WANG, J.P., LIN, C.N., WU, T.S., CHEN, C.C. & HUANG, T.F. (1991). Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J. Pharm. Pharmacol., 43, 667-669.
41. TSAI, T.H., TSAI, W.J., CHOU, C.J. & CHEN, C.F. (1995). Magnolol inhibits collagen-induced platelet serotonin release. Thromb. Res., 78, 265-270.
42. VAUX, D.L. & KORSMEYER, S.J. (1999). Cell death in development. Cell, 96, 245-254.
43. VERHEIJ, M., BOSE, R., LIN, X.H., YAO, B., JARVIS, W.D., GRANT, S., BIRRER, M.J., SZABO, E., ZON, L.I., KYRIAKIS, J.M., HAIMOVITZ-FRIEDMAN, A., FUKS, Z. & KOLESNICK, R.N. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature, 380, 75-79.
44. WANG, J.P., HSU, M.F., RAUNG, S.L., CHEN, C.C., KUO, J.S. & TENG, C.M. (1992). Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch. Pharmacol., 346, 707-712.
45. WATANABE, K., WATANABE, H., GOTO, Y., YAMAGUCHI, M., YAMAMOTO, N. & HAGINO, K. (1983). Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med., 49, 103-108.
46. WATANABE, K., WATANABE, H.Y., GOTO, Y., YAMAMOTO, N. & YOSHIZAKI, M. (1975). Studies on the active principles of magnolia bark. Centrally acting muscle relaxant activity of magnolol and honokiol. Jpn J. Pharmacol., 25, 605-607.
47. WORDEN, F.P. & KALEMKERIAN, G.P. (2000). Therapeutic advances in small cell lung cancer. Expert. Opin. Investig. Drugs, 9, 565-579.
48. XIA, Z., DICKENS, M., RAINGEAUD, J., DAVIS, R.J. & GREENBERG, M.E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
49. YANG, C.H., TSAI, C.M., WANG, L.S., LEE, Y.C., CHANG, C.J., LUI, L.T., YEN, S.H., HSU, C., CHENG, A.L., LIU, M.Y., CHIANG, S.C., CHEN, Y.M., LUH, K.T., HUANG, M.H., YANG, P.C. & PERNG, R.P. (2002). Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer. Br. J. Cancer, 86, 190-195.
50. YANG, E., ZHA, J., JOCKEL, J., BOISE, L.H., THOMPSON, C.B. & KORSMEYER, S.J. (1995). Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-291.
51. YANG, J., LIU, X., BHALLA, K., KIM, C.N., IBRADO, A.M., CAI, J., PENG, T.I., JONES, D.P. & WANG, X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, 1129-1132.
52. ZOU, H., HENZEL, W.J., LIU, X., LUTSCHG, A. & WANG, X. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90, 405-413.